epidemiologyЭпидемиология и ВакцинопрофилактикаEpidemiology and Vaccinal Prevention2073-30462619-0494«Numicom» LLC10.31631/2073-3046-2022-21-3-117-120epidemiology-1566Research ArticleОБЗОРREVIEWВоздействие неспецифических противоэпидемических мер против СOVID-19 на заболеваемость бактериальными гнойными менингитами во время пандемииImpact of Nonspecific Antipidemic Measures against COVID-19 on the INCIDENCE of Acute Purulent Meningitis during the PandemicКостюковаН. Н.KostyukovaN. N.

Наталья Николаевна Костюкова  – д. м. н., профессор, ведущий научный сотрудник

+7 (499)193-61-51, +7 (499) 249-69-24

Natalya N. Kostyukova  – Dr. Sci. (Med.), Professor, Leading Researcher

Moscow

+7 (499) 193-61-51, +7 (499) 249-69-24

nathakos@mail.ruБехалоВ. А.BekhaloV. A

Владимир Андреевич Бехало  – к. м. н., ведущий научный сотрудник

+7(916)935 41 42

Vladimir A. Behalo – Cand. Sci. (Med.), Leading Researcher

Moscow

+ 7(916)935 41 42

bekhalo@gamaleya.orgФГБУ «НИЦ эпидемиологии и микробиологии им. Н. Ф. Гамалеи» Минздрава РФРоссияThe National Research Center for Epidemiology and Microbiology named after Honorary Academician N. F. GamaleyaRussian Federation202210072022213117120Copyright © Костюкова Н.Н., Бехало В.А., 20222022Костюкова Н.Н., Бехало В.А.Kostyukova N.N., Bekhalo V.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.epidemvac.ru/jour/article/view/1566

Актуальность. Неспецифические противоэпидемические меры против СOVID-19 (ношение масок, социальное дистанцирование, локдауны, работа на дому, карантины, закрытие школ, запрет туризма и т.п.) привели к значительному снижению заболеваемости многими респираторными инфекциями. В научных публикациях появилась информация о снижении заболеваемости бактериальными гнойными менингитами (БГМ) в период развития пандемии СOVID-19. Цель. Рассмотреть научные публикации о снижении заболеваемости БГМ в период развития пандемии СOVID-19. Выводы. Несомненно, неспецифические противоэпидемические меры, предпринимаемые в период пандемии COVID-19, способствовали сокращению заболеваемости респираторными инфекциями независимо от их этиологии и могли служить косвенным индикатором активности этих мер.

Relevance. Nonspecific anti-epidemic measures against СOVID-19 (mask-wearing, social distancing, lockdowns, homework, quarantines, school closures, tourism bans, etc.) resulted in a significant decrease in the incidence of many respiratory infections. Scientific publications have reported a decrease in the incidence of bacterial purulent meningitis (BMP) during the development of the COVID-19 pandemic. Aims. To review the scientific publications on the decline in the incidence of BMP during the СOVID-19 pandemic. Conclusions. Undoubtedly non-specific anti-epidemic measures taken during the COVID-19 pandemic helped to reduce the incidence of respiratory infections regardless of their etiology and could serve as an indirect indicator of the activity of these measures.

COVID-19. неспецифические противоэпидемические мерыреспираторные инфекциибактериальные гнойные менингитыпандемияCOVID-19non-specific anti-epidemic measuresrespiratory infectionsbacterial purulent meningitispandemicReferencesBrueggemann A.B., van Rensberg M.J.J., Shaw D., et al. Changes of the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the invasive Respiratory Surveillance Initiatives: a prospective analysis of surveillance data. Lancet Digit Health, 2021 3:e360–370.Brueggemann A.B., van Rensberg M.J.J., Shaw D., et al. Changes of the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the invasive Respiratory Surveillance Initiatives: a prospective analysis of surveillance data. Lancet Digit Health, 2021 3:e360–370.Kadambari S., Goldacre R., Morris E., et al. Indirect effectiveness of the covid-19 pandemic on childhood infection in England: population based observation study. BMJ. 2022;376: e067519.Kadambari S., Goldacre R., Morris E., et al. Indirect effectiveness of the covid-19 pandemic on childhood infection in England: population based observation study. BMJ. 2022;376: e067519.Anderson M.R., Arkwright P.D., Bai X., et al. Surveillance and control of meningococcal disease in the COVID-19 era: a Global Meningococcal Initiative review. J. Infection, 2022,84:289–296.Anderson M.R., Arkwright P.D., Bai X., et al. Surveillance and control of meningococcal disease in the COVID-19 era: a Global Meningococcal Initiative review. J. Infection, 2022,84:289–296.Subbarao S., Campbell H., Ribeiro S. et al. Invasive meningococcal disease, 2011-2020, and impact of COVID-19 pandemic, England. Emerg. Infect. Dis., 2021;27( 9):2495–2497.Subbarao S., Campbell H., Ribeiro S. et al. Invasive meningococcal disease, 2011-2020, and impact of COVID-19 pandemic, England. Emerg. Infect. Dis., 2021;27( 9):2495–2497.Ladhani S.N., Andrew S. N., Rarikh S.R., et al. Vaccination of infants with meningococcal group B vaccine (4CMenB) in England. N.Engl. Med. J. 2020;382:309–317.Ladhani S.N., Andrew S. N., Rarikh S.R., et al. Vaccination of infants with meningococcal group B vaccine (4CMenB) in England. N.Engl. Med. J. 2020;382:309–317.Clark A., Campbell H., Mensah A.A., et al. An increase in group B invasive meningococcal infection disease among adolescents and young adults in England following easing of COVID-19 containment measures. Preprint. SSRN:https://ssrn.com/abstract=3998164Clark A., Campbell H., Mensah A.A., et al. An increase in group B invasive meningococcal infection disease among adolescents and young adults in England following easing of COVID-19 containment measures. Preprint. SSRN:https://ssrn.com/abstract=3998164 McMillan M., Walters L., Sullivan T., et al. Impact of meningococcal B (4CMenB) vaccine on pharyngeal Neisseria meningitidis carriage density and persistence in adolescents. Clin. Infect. Dis. 2021;73 (1):e99–106.McMillan M., Walters L., Sullivan T., et al. Impact of meningococcal B (4CMenB) vaccine on pharyngeal Neisseria meningitidis carriage density and persistence in adolescents. Clin. Infect. Dis. 2021;73 (1):e99–106.Taha M.Kh., Deghmane A.E. Impact of COVID-19 pandemic and the lock-down on invasive meningococcal disease. BMC Res. Notes. 2020;13:399.Taha M.Kh., Deghmane A.E. Impact of COVID-19 pandemic and the lock-down on invasive meningococcal disease. BMC Res. Notes. 2020;13:399.Ktena D.,Kourkouni E., Kontopidou S., et al. Population based of influenza and invasive meningococcal disease among Greek children during the COVID-19 pandemic. BMJ Paeditrics Open. 2022;6:e001391.Ktena D.,Kourkouni E., Kontopidou S., et al. Population based of influenza and invasive meningococcal disease among Greek children during the COVID-19 pandemic. BMJ Paeditrics Open. 2022;6:e001391.George C.R.R., Booy R., Nissen M.D., Lahra M.U. The decline of invasive meningococcal disease and influenza in the time of COVID-19 : the silver linings of the pandemic playbook. Med. J. Aust. Mar 27. doi: 10.5694/mja2.51463. Epub ahead of print. PMID: 35340025George C.R.R., Booy R., Nissen M.D., Lahra M.U. The decline of invasive meningococcal disease and influenza in the time of COVID-19 : the silver linings of the pandemic playbook. Med. J. Aust. Mar 27. doi: 10.5694/mja2.51463. Epub ahead of print. PMID: 35340025Kim.J.K., Choi Y.Y., Lee H., et al. Differential impact of non-pharmaceutical interventions on the epidemiology of invasive meningococcal infections in children during the coronavirus disease 2019 pandemic. Pediat. Infect. Dis. J. 2022;41:91–96.Kim.J.K., Choi Y.Y., Lee H., et al. Differential impact of non-pharmaceutical interventions on the epidemiology of invasive meningococcal infections in children during the coronavirus disease 2019 pandemic. Pediat. Infect. Dis. J. 2022;41:91–96.Willen L., Ekinci E., Cuipers L., et al. Infant pneumococcal carriage in Belgium not affected by COVID-19 containment measures. Frontiers in Cell. Infect. Microbiol. 2022;11:825427.Willen L., Ekinci E., Cuipers L., et al. Infant pneumococcal carriage in Belgium not affected by COVID-19 containment measures. Frontiers in Cell. Infect. Microbiol. 2022;11:825427.Dirkx K.K.T., Mulder B., Post S.A., et al. The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained. Intern. J. Infect. Dis. 2021:11196–203.Dirkx K.K.T., Mulder B., Post S.A., et al. The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained. Intern. J. Infect. Dis. 2021:11196–203.Casanova C., Kuiffer M., Leib St.L., Helty M. Re-emergence of invasive pneumococcal disease (IPD) and increase of serotype 23B after easing of COVID-19 measures, Switzerland, 2021. Emerging Microb. Infect., 2021, Dec.10(1):2202–2204.Casanova C., Kuiffer M., Leib St.L., Helty M. Re-emergence of invasive pneumococcal disease (IPD) and increase of serotype 23B after easing of COVID-19 measures, Switzerland, 2021. Emerging Microb. Infect., 2021, Dec.10(1):2202–2204.Грицай М. И., Королева М. А., Королева И. С. Особенности менингококковой инфекции в Москве в 2020 г. Журнал инфектологии. 2022;14(1), Приложение, с.13Koroleva M.A., Koroleva I.S., Gritsay M.I. Etiologic structure of purulent bacterial meningitis in Russian Federation. J.Infectiology. 2022;1, Suppl.:20 (in Russ,).Королева М. А., Миронов К. О., Королева И. С. Эпидемиологические особенности генерализованных форм менингококковой инфекции, обусловленных Neisseria meningitidis серогруппы W в мире и в Российской Федерации. Эпидемиология и инфекционные болезни. Актуальные вопросы. 2018;3:16–23.Koroleva M.A., Mironov K.O., Koroleva I.S. Epidemiologocal characteristics of generilized meningococcal infection caused by Neisseria meningitidis serogroup W in the world and in Russian Fedderation. Epidemiology and Vaccine Prevention (in Russ.), 2018, 3:16-23Baker R.E., Park S.W., Yang W., et al. The impact of COVID-19 non-pharmaceutical interventions on the future dynamics of endemic infections. PNAS. 2920;117(48):30547–30553.Baker R.E., Park S.W., Yang W., et al. The impact of COVID-19 non-pharmaceutical interventions on the future dynamics of endemic infections. PNAS. 2920;117(48):30547–30553.Binns E., Koenraads L., Hristeva L., et al. Influenza and respiratory syntycial virus during COVID-19 pandemic: time for new paradigm? Pediatric Pulmonology. 2022;57(1):38–42.Binns E., Koenraads L., Hristeva L., et al. Influenza and respiratory syntycial virus during COVID-19 pandemic: time for new paradigm? Pediatric Pulmonology. 2022;57(1):38–42.Groves H.E., Piche-Renaud P.-Ph., Peci A., et al. The impact of COVID-19 pandemic on influenza, respiratory syntycial virus, and other seasonal respiratory virus circulation in Canada: a population-based study. The Lancet Regional Health – Americas. 2021;1:100015.Groves H.E., Piche-Renaud P.-Ph., Peci A., et al. The impact of COVID-19 pandemic on influenza, respiratory syntycial virus, and other seasonal respiratory virus circulation in Canada: a population-based study. The Lancet Regional Health – Americas. 2021;1:100015.Ippolito G., LaVecchia A., Umbrello G., et al. Disappearance of seasonal respiratory viruses in children under two years old during COVID-19 pandemic: a monocentric retrospective study in Milan. Italy. Frontiers in Pediatrics. 2021;9:721005.Ippolito G., LaVecchia A., Umbrello G., et al. Disappearance of seasonal respiratory viruses in children under two years old during COVID-19 pandemic: a monocentric retrospective study in Milan. Italy. Frontiers in Pediatrics. 2021;9:721005.Соминина А. А., Даниленко Д. М., Столяров К. А. и др. Интерференция SARS-CoV-2 с другими возбудителями респираторных вирусных инфекций в период пандемии. Эпидемиология и Вакцинопрофилактика. 2021;4:28–39.Sominina A.A., Danilenko D.V., Stolyarov K.A., Karpova L.S., Bakaev M.I., Levanyuk T.R. et al. Interference of SARS-CoV-2 with the respiratory viral infection agents during pandemic. Epidemiology and Vaccinal Prevention. 2021;4:28–39 (in Russ.).

The authors declare that there are no conflicts of interest present.